PMI-150 (intranasal ketamine)
DrugPMI-150 (intranasal ketamine) at time 0 and scheduled times thereafter.
NCT Number: NCT00709436
The purpose of this research study is to evaluate the safety and analgesic efficacy of PMI-150 (intranasal ketamine) compared to placebo in patients with acute post-operative pain following orthopedic trauma, injury, or surgery.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 3
Jefferson Clinic, Birmingham, Alabama, United States
Patients will be randomly assigned to PMI-150 (intranasal ketamine) or placebo and will receive repeated doses and be assessed for safety and efficacy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PMI-150 (intranasal ketamine) at time 0 and scheduled times thereafter.
Placebo (intranasal) at time 0 and scheduled times thereafter.
Time frame: 0-6 hours
Hospira, now a wholly owned subsidiary of Pfizer
Industry
Randomized, Multiple-center, Double-blind, Placebo-controlled Study of the Safety and Analgesic Efficacy of Repeated Dosing of PMI-150 (Intranasal Ketamine) to Treat Acute Post-operative Pain Following Orthopedic Trauma, Injury, or Surgery.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05405088
Anxiety Disorders, Anxiety, Dental
Clermont-Ferrand, France
View Trial DetailsNCT04641338
Neurologic Manifestations, Pain
Ijuí, Rio Grande do Sul, Brazil
View Trial DetailsNCT05811208
Confusion, Delirium
Brno, Czech Republic, Czechia
View Trial Details